Abilify vs. Vraylar

• Are Vraylar and Abilify the Same Thing?
• What Are Possible Side Effects of Abilify?
• What Are Possible Side Effects of Vraylar?
• What is Abilify?
• What is Vraylar?
• What Drugs Interact with Abilify?
• What Drugs Interact with Vraylar?
• How Should Abilify Be Taken?
• How Should Vraylar Be Taken?

Abilify (aripiprazole) and Vraylar (cariprazine) are antipsychotic medications used to treat schizophrenia and mania.

Abilify is also used to treat depression, bipolar disorders, autistic disorder, and some irritable behavior disorders.

Common side effects of Abilify include:

• dizziness
• lightheadedness
• drowsiness
• weakness
• lightheadedness
• nausea
• vomiting
• stomach upset
• tiredness
• excess saliva or drooling
• choking or trouble swallowing
• blurred vision
• headache
• anxiety
• weight gain
• drowsiness
• sleep problems (insomnia)
• constipation

Common side effects of Vraylar include:

• extrapyramidal symptoms (muscle spasms, muscle rigidity, tremor, jerking movements),
• agitation,
• indigestion,
• nausea,
• vomiting,
• sleepiness,
• restlessness,
• weight gain,
• headache,
• insomnia,
• abdominal pain,
• constipation,
• toothache,
• anxiety,
• diarrhea,
• pain in the extremities,
• dry mouth,
• loss of appetite,
• back pain,
• dizziness, and
• cough.

Abilify (aripiprazole) is a psychotropic drug (antipsychotic) that alters brain chemical activity used to treat schizophrenia, mania, depression, bipolar disorders, autistic disorder, and some irritable behavior disorders. Generic Abilify is not available in the U.S., but is available in other countries under the name aripiprazole.

Vraylar (cariprazine) is an atypical antipsychotic indicated for the treatment of schizophrenia, and the acute treatment of manic or mixed episodes associated with bipolar I disorder.

Abilify (aripiprazole) is a psychotropic drug (antipsychotic) that alters brain chemical activity used to treat schizophrenia, mania, depression, bipolar disorders, autistic disorder, and some irritable behavior disorders. Generic Abilify is not available in the U.S., but is available in other countries under the name aripiprazole.

Abilify may also interact with rifabutin, rifampin, or quinidine.

Acute withdrawal symptoms, such as insomnia, nausea, and vomiting may occur if you suddenly stop taking Vraylar.

Vraylar may interact with CYP3A4 inducers and inhibitors. Tell your doctor all medications and supplements you use.

Abilify is available in tablet, orally disintegrating tablets, oral solution and injectable formulations. Dosage is variable and depends on multiple factors such as the ongoing mental problem, patient age, and other factors to be determined by the prescribing doctor. Abilify has been used in the pediatric population but such use should be discussed with a pediatric specialist. Abilify may interact with other medicines that make you sleepy (such as cold or allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety), medications to treat high blood pressure or a heart condition, carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, ketoconazole, itraconazole, quinidine, fluoxetine, fluvoxamine, or paroxetine. Tell your doctor all medications and supplements you use. Benefits should outweigh risks in pregnant women. Women who are breastfeeding should not take Abilify.

The starting dose of Vraylar is 1.5 mg once daily.